European Parliament: Reform for better patient care required

Veröffentlicht:

Von:

Meta-Beschreibung: "Erfahren Sie, wie Pharma Deutschland die Reform der Medizinprodukteverordnung (MDR) unterstützt, um Patientenversorgung zu sichern, Bürokratie abzubauen und den Marktzugang für Hersteller in der EU zu erleichtern. Lesen Sie die zentralen Forderungen und Maßnahmen zur Stärkung der Innovationskraft in der Pharmaindustrie."
META description: "Learn how Pharma Germany supports the reform of the Medical Device Ordinance (MDR) to secure patient care, reduce bureaucracy and to facilitate market access for manufacturers in the EU. Read the central demands and measures to strengthen innovative strength in the pharmaceutical industry." (Symbolbild/MB)

A true sensation in the health sector! The European Parliament has triggered a cry for change today with an overwhelming majority: the revision of the Medical Device Ordinance (MDR). MEPs urgently demand from the European Commission to reform the complex rules for medical devices in the EU from scratch and thus focus on patient care. This requirement finds strong support from Pharma Germany, the mighty industry association, which presents clear measures in order to ensure the innovative strength of the pharmaceutical industry and to close critical care gaps.

"The current regulation suffocates innovation and creates massive hurdles that manufacturers have showered when they think of investments in the European market," explains Dorothee Brakmann, the strong voice of Pharma Germany. "We now need more quickly and practical changes to ensure efficient and safe patient care throughout the EU!" The expectations are high: the association calls on the European Commission to submit specific suggestions for the MDR reform within the first 100 days after taking office. It is time to reduce the bureaucratic effort and to make the European market more attractive for manufacturers!

urgency of the reform

Pharma Germany does not stand by and not on the sidelines - they have developed a comprehensive proposal to change the MDR. The urgency of a rapid reform is clear: This is the only way to guarantee patient care and at the same time the market access can be made easier. The focus of the demands is five central points that are clearly addressed to the industry. Every detail counts when it comes to setting the course for better medical care!

For all interested parties there is the complete statement of Pharma Germany on their website - including all demands in tabular form and in English. Only together can we master the challenges of the medical device industry and make a real difference in the life of the patients!

Pharma Deutschland e.V. represents about 80,000 employees in Germany with over 400 member companies and plays a crucial role in pharmaceutical supply: they provide almost 80 percent of the over -the -counter and two thirds of the prescription medicines. Find out more about the latest developments and how Pharma Germany actively influences health care! Visit the website at www.pharmadeutschland.de.